In this study, we developed the first mouse models expressing either wild‐type (WT) human CCNF or its mutant pathogenic variant S621G, which recapitulate key clinical presentations of FTD and neuropathological features of both ALS and FTD linked to CCNF disease variants. This evidence concerns the gene CCNF and amyotrophic lateral sclerosis.